# Camtek Ltd. share price today (Camtek Ltd., CAMT)

> Camtek Ltd.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. CAMT · Technology · Semiconductor Equipment & Materials · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/camt

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Getting worse, from the last 12 quarters
- Price: $112.37 (−9.2% in a year)
- P/E: 144.3×, over 4.6 years
- Revenue (Jun 2026): $133 M (+8.0% on a year ago)
- Profit (Jun 2026): $23.3 M (−30.8% on a year ago)
- Operating margin: 20.4% (−5.5 points on a year ago)
- ROE: 8%, FY25
- ROIC: 18.3%, against a 12.7% cost of capital: +5.6 points

The main question: the share price moved −9.2% in a year while yearly earnings per share moved −56.9%. The difference came from the market paying a higher multiple. ## What is the Camtek Ltd. share price today? Camtek Ltd.'s share price was $112.37 at the close on 3 November 2026. It has been moving sideways for 5 weeks. That is 28.5% below its average price over the last 200 trading days. In the last 52 weeks it traded between $94 and $206, and at that close it sat 16% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 4 weeks running. Over the last 10 years the share price moved +4,872% while the S&P 500 moved +255%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 9 October 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Camtek Ltd. pay? Camtek Ltd. has 1 quarter of declared dividends on file, too few for a 12-month total. The most recent declaration was $1.33 for Mar 2024. Camtek Ltd. declared a dividend in 1 of the last 12 reported quarters, most recently $1.33 for Mar 2024. That is fewer than four quarters, so no 12-month total is shown. ## Which stock lists is Camtek Ltd. on? Camtek Ltd. is on one of our US lists: US tech stocks. [US tech stocks](https://www.sectoralpha.in/us-tech-stocks)

## Is Camtek Ltd. profitable? Camtek Ltd. earned $23.3 M of net profit in the Jun 2026 quarter, −30.8% on the same quarter a year earlier. Full-year FY25 profit was $50.7 M. Over 4 years profit has grown −4.2% a year on average. That is 17.5% of the quarter's revenue. The same quarter a year earlier earned $33.7 M. 1 of the last 12 reported quarters were loss-making. For the full year, FY25 profit was $50.7 M (−57.2% on the year before). Why profit moved: revenue changed +8.0% on a year earlier and the margin moved −5.5 percentage points. Sales did the work while the margin got thinner. On average over the last four quarters, profit changed −73.1% and revenue +8.0%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does Camtek Ltd. make, and is it growing? Camtek Ltd. reported $133 M of revenue in the Jun 2026 quarter, +8.0% on the same quarter a year earlier. That is the 11th quarter in a row with growth on the year before. Over 4 years it has grown 16.5% a year on average. The last full year, FY25, came in at $496 M. The last four reported quarters add to $509 M. FY25 revenue was $496 M, +15.6% on the year before. Recent pace: the last four quarters grew +8.0% on average, against 16.5% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +7.9%, against +17.5% a year over the last 8 quarters (rolling over); profit over the last 12 months grew −71.8%, against −37.2% a year (rolling over). ## How much of every $100 of sales does Camtek Ltd. keep? Camtek Ltd.'s operating margin was 20.4% in the Jun 2026 quarter, 5.5 percentage points lower than the same quarter a year ago. Its latest full-year margin is the highest it has ever reported. Across 5 years it has been between 20.7% and 26.6%. The latest quarter is below every full year in that period. Across 5 years it has been between 20.7% and 26.6%, and FY25's 26.6% is the highest of them. Why the margin moved: operating margin changed −5.5 percentage points on the year while gross margin changed −0.7 points. So the drop came mostly from costs below the gross margin, such as staff and overheads, measured against sales. When margins are at a record, every ratio built on profit looks better than usual, so watch whether they hold. ## Is Camtek Ltd.'s profit turning into cash? Over the last 3 years, 139% of Camtek Ltd.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $142 M of operating cash against $50.7 M of profit. After $14.4 M of spending on assets, $127 M was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Camtek Ltd.'s cash go? Camtek Ltd. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $32.6 M on assets over the last 3 years. Averaged over those years that is 2.2% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $32.6 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Camtek Ltd.'s P/E ratio, and how does it compare with its own history? Camtek Ltd.'s P/E is 144.3×, with too little history to compare. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved −56.9% while the price moved −9.2%. The price did better than earnings, which pushed the multiple up within its own range. Where the price move came from: over 3 years the price moved +25.8% a year; about −27.5% a year came from earnings growth and about +53.3 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: there is too little history to say whether the multiple is high or low for this company, so the earnings trend underneath matters more than the multiple. ## Is the Camtek Ltd. business getting better or worse? Camtek Ltd.'s business is getting worse. Profit and EPS growth are shrinking: profit growth is −71.8% in the latest quarter, against +50.7% at its best in 12 quarters, with ROCE falling at 11.8%. This is based on 12 quarters of 4 measures. Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind. ## How much does Camtek Ltd. earn on its capital? Camtek Ltd. earned a ROE of 8% in FY25. Its return on capital used (ROIC) is 5.6 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 10.2% net margin and 0.39× asset turnover (sales divided by assets). Why the return is what it is (FY25): a 10.2% net margin × 0.39× asset turnover × 2.04× leverage (assets divided by equity) ≈ 8.1% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 18.3% − 12.7% = +5.6 percentage points. The 12.7% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. A gap this wide means each dollar put back into the business creates more than a dollar of value. The 18.3% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at 30.2%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Camtek Ltd. have too much debt? Camtek Ltd. has total debt of $488 M against shareholder equity of $710 M as of Jun 2026, so its debt is 0.69× its equity. Year by year, that ratio went from 0.67 in FY21 to 0.86 in FY25. Keep that borrowing in mind when reading the returns on this page. ## What is the Camtek Ltd. shareholding pattern? We have no ownership or short-position figures for Camtek Ltd., so this section says so rather than fill the gap. At normal trading volumes, closing those positions would take about 4.7 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. ## How far is Camtek Ltd. from balance-sheet trouble? For Camtek Ltd., the Z-score is 6.60. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 6.60 is well clear of the danger zone, so the balance sheet is not the risk here. ## How does Camtek Ltd. rank in its industry? 40.2 out of 100, rank 21 of 29 in Semiconductor Equipment & Materials, with 81% of the evidence available. Camtek Ltd. scores 40.2 out of 100 against the 29 companies it is compared with in Semiconductor Equipment & Materials, ranking 21. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 7.6 + 13.8 + 12.5 + 6.3 = 40.2. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Camtek Ltd. compared with? Camtek Ltd. ranks 21 of 29 Semiconductor Equipment & Materials companies on the 4-Factor Sector Score, with 40.2 out of 100. 1. [ASML Holding N.V.](https://www.sectoralpha.in/us/stocks/asml) ASML · quiet · Most evidence points up · 85% evidence 76.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.6/35 · Revenue 22.5% · Profit 42.4% · Operating margin change 11.6 points · 95% evidence Capital efficiency 21.0/25 · ROCE 44.7% · Operating margin 44.4% · 76% evidence Valuation 13.2/20 · P/E 43.3× · PEG 0.97 · 65% evidence Relative strength 17.0/20 · Lead over its industry 6.6% · Lead over S&P 500 -1% · 1 year 52.6% · 100% evidence · 1 of 12 weeks ahead Exact sum: 25.6 + 21 + 13.2 + 17 = 76.8 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [Lam Research Corporation](https://www.sectoralpha.in/us/stocks/lrcx) LRCX · quiet · Most evidence points up · 85% evidence 71.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 29.2/35 · Revenue 33.4% · Profit 45.4% · Operating margin change 5.6 points · 95% evidence Capital efficiency 21.4/25 · ROCE 50.7% · Operating margin 40% · 76% evidence Valuation 13.0/20 · P/E 46.7× · PEG 0.97 · 65% evidence Relative strength 7.5/20 · Lead over its industry -7% · Lead over S&P 500 -15.3% · 1 year 44.8% · 100% evidence · 0 of 12 weeks ahead Exact sum: 29.2 + 21.4 + 13 + 7.5 = 71.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Teradyne, Inc.](https://www.sectoralpha.in/us/stocks/ter) TER · losing its lead · Most evidence points up · 81% evidence 68.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 31.0/35 · Revenue 57.8% · Profit 100% · Operating margin change 18.9 points · 83% evidence Capital efficiency 20.4/25 · ROCE 36.7% · Operating margin 33.2% · 76% evidence Valuation 11.8/20 · P/E 59.5× · PEG 1.03 · 65% evidence Relative strength 5.2/20 · Lead over its industry -10.4% · Lead over S&P 500 -18.7% · 1 year 47.8% · 100% evidence · 2 of 12 weeks ahead Exact sum: 31 + 20.4 + 11.8 + 5.2 = 68.4 · What this means: Earnings are strong; relative strength in its sector is -10.4% and the one-year return is 47.8%. 4. [KLA Corporation](https://www.sectoralpha.in/us/stocks/klac) KLAC · quiet · Evidence leans up · 85% evidence 62.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.3/35 · Revenue 15.8% · Profit 24.1% · Operating margin change 3.3 points · 95% evidence Capital efficiency 21.1/25 · ROCE 44.7% · Operating margin 45% · 76% evidence Valuation 8.7/20 · P/E 48.4× · PEG 1.91 · 65% evidence Relative strength 10.4/20 · Lead over its industry -4.5% · Lead over S&P 500 -12.3% · 1 year 30.9% · 100% evidence · 0 of 12 weeks ahead Exact sum: 22.3 + 21.1 + 8.7 + 10.4 = 62.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [FormFactor, Inc.](https://www.sectoralpha.in/us/stocks/form) FORM · losing its lead · Evidence leans up · 81% evidence 60.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.3/35 · Revenue 18.1% · Profit 100% · Operating margin change 17.8 points · 83% evidence Capital efficiency 15.8/25 · ROCE 12.7% · Operating margin 24.1% · 76% evidence Valuation 4.6/20 · P/E 88.3× · PEG 4.6 · 65% evidence Relative strength 11.9/20 · Lead over its industry 0.5% · Lead over S&P 500 -9.8% · 1 year 85.2% · 100% evidence · 2 of 12 weeks ahead Exact sum: 28.3 + 15.8 + 4.6 + 11.9 = 60.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Kulicke and Soffa Industries, Inc.](https://www.sectoralpha.in/us/stocks/klic) KLIC · quiet · Evidence leans up · 64% evidence 60.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.1/35 · Revenue 44.8% · Profit 100% · Operating margin change 20 points · 62% evidence Capital efficiency 14.3/25 · ROCE 12.5% · Operating margin 20.7% · 76% evidence Valuation 10.1/20 · P/E 54.9× · PEG n/a · 15% evidence Relative strength 11.5/20 · Lead over its industry -1.7% · Lead over S&P 500 -11.7% · 1 year 88.5% · 100% evidence · 0 of 12 weeks ahead Exact sum: 24.1 + 14.3 + 10.1 + 11.5 = 60 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Cohu, Inc.](https://www.sectoralpha.in/us/stocks/cohu) COHU · losing its lead · Evidence leans up · 64% evidence 58.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.4/35 · Revenue 32.5% · Profit n/a · Operating margin change 15.4 points · 62% evidence Capital efficiency 4.8/25 · ROCE -2.9% · Operating margin 0.6% · 76% evidence Valuation 10.8/20 · P/E 27.1× · PEG n/a · 15% evidence Relative strength 19.6/20 · Lead over its industry 25.9% · Lead over S&P 500 12.6% · 1 year 109.1% · 100% evidence · 3 of 12 weeks ahead Exact sum: 23.4 + 4.8 + 10.8 + 19.6 = 58.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Applied Materials, Inc.](https://www.sectoralpha.in/us/stocks/amat) AMAT · quiet · Evidence leans up · 85% evidence 57.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.8/35 · Revenue 7.8% · Profit 35.6% · Operating margin change 3.1 points · 95% evidence Capital efficiency 20.1/25 · ROCE 29% · Operating margin 33.7% · 76% evidence Valuation 11.4/20 · P/E 45.9× · PEG 1.21 · 65% evidence Relative strength 9.0/20 · Lead over its industry -1% · Lead over S&P 500 -10.2% · 1 year 66% · 100% evidence · 1 of 12 weeks ahead Exact sum: 16.8 + 20.1 + 11.4 + 9 = 57.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Amkor Technology, Inc.](https://www.sectoralpha.in/us/stocks/amkr) AMKR · quiet · Evidence leans up · 81% evidence 54.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.8/35 · Revenue 17.9% · Profit 82.9% · Operating margin change 4.4 points · 83% evidence Capital efficiency 12.4/25 · ROCE 8.5% · Operating margin 10.5% · 76% evidence Valuation 14.8/20 · P/E 38.5× · PEG 0.68 · 65% evidence Relative strength 2.6/20 · Lead over its industry -26.9% · Lead over S&P 500 -33% · 1 year 8.2% · 100% evidence · 0 of 12 weeks ahead Exact sum: 24.8 + 12.4 + 14.8 + 2.6 = 54.6 · What this means: Earnings are strong; relative strength in its sector is -26.9% and the one-year return is 8.2%. 10. [Photronics, Inc.](https://www.sectoralpha.in/us/stocks/plab) PLAB · quiet · Evidence leans up · 85% evidence 53.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 14.2/35 · Revenue 1.3% · Profit 51.4% · Operating margin change -1.8 points · 95% evidence Capital efficiency 15.2/25 · ROCE 10.9% · Operating margin 21.1% · 76% evidence Valuation 16.0/20 · P/E 10.8× · PEG 0.43 · 65% evidence Relative strength 8.1/20 · Lead over its industry -17.1% · Lead over S&P 500 -21.8% · 1 year 29% · 100% evidence · 1 of 12 weeks ahead Exact sum: 14.2 + 15.2 + 16 + 8.1 = 53.5 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 11. [Entegris, Inc.](https://www.sectoralpha.in/us/stocks/entg) ENTG · losing its lead · Evidence leans up · 81% evidence 53.0 out of 100 Growth Capital Valuation Relative
12. InTest Corporation INTT · turning · Evidence leans up · 64% evidence 52.2 out of 100 Growth Capital Valuation Relative
13. [Qnity Electronics, Inc.](https://www.sectoralpha.in/us/stocks/q) Q · quiet · Evidence leans up · 65% evidence 52.1 out of 100 Growth Capital Valuation Relative
14. [AXT, Inc.](https://www.sectoralpha.in/us/stocks/axti) AXTI · losing its lead · Evidence leans up · 64% evidence 52.0 out of 100 Growth Capital Valuation Relative
15. [IPG Photonics Corporation](https://www.sectoralpha.in/us/stocks/ipgp) IPGP · basing · Evidence leans down · 74% evidence 49.1 out of 100 Growth Capital Valuation Relative
16. [Ambarella, Inc.](https://www.sectoralpha.in/us/stocks/amba) AMBA · quiet · Evidence leans down · 67% evidence 48.0 out of 100 Growth Capital Valuation Relative
17. [Amtech Systems, Inc.](https://www.sectoralpha.in/us/stocks/asys) ASYS · quiet · Evidence leans down · 64% evidence 44.5 out of 100 Growth Capital Valuation Relative
18. [Nova Ltd.](https://www.sectoralpha.in/us/stocks/nvmi) NVMI · basing · Evidence leans down · 81% evidence 43.5 out of 100 Growth Capital Valuation Relative
19. [Onto Innovation Inc.](https://www.sectoralpha.in/us/stocks/onto) ONTO · quiet · Too little evidence to rank firmly · 56% evidence 41.6 out of 100 Growth Capital Valuation Relative
20. [Aehr Test Systems, Inc.](https://www.sectoralpha.in/us/stocks/aehr) AEHR · losing its lead · Evidence leans down · 64% evidence 41.4 out of 100 Growth Capital Valuation Relative
21. Camtek Ltd. this page CAMT · quiet · Evidence leans down · 81% evidence 40.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 7.6/35 · Revenue 8.1% · Profit -71.6% · Operating margin change -5.5 points · 83% evidence Capital efficiency 13.8/25 · ROCE 10% · Operating margin 20.4% · 76% evidence Valuation 12.5/20 · P/E 202.1× · PEG 0.75 · 65% evidence Relative strength 6.3/20 · Lead over its industry -22.1% · Lead over S&P 500 -27.5% · 1 year -5.7% · 100% evidence · 1 of 12 weeks ahead Exact sum: 7.6 + 13.8 + 12.5 + 6.3 = 40.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 22. [ACM Research, Inc.](https://www.sectoralpha.in/us/stocks/acmr) ACMR · quiet · Evidence leans down · 81% evidence 38.6 out of 100 Growth Capital Valuation Relative
23. [Veeco Instruments Inc.](https://www.sectoralpha.in/us/stocks/veco) VECO · quiet · Evidence leans down · 81% evidence 37.3 out of 100 Growth Capital Valuation Relative
24. [Axcelis Technologies, Inc.](https://www.sectoralpha.in/us/stocks/acls) ACLS · quiet · Evidence leans down · 81% evidence 36.9 out of 100 Growth Capital Valuation Relative
25. [Ichor Holdings, Ltd.](https://www.sectoralpha.in/us/stocks/ichr) ICHR · quiet · Evidence leans down · 64% evidence 35.4 out of 100 Growth Capital Valuation Relative
26. [Ultra Clean Holdings, Inc.](https://www.sectoralpha.in/us/stocks/uctt) UCTT · quiet · Most evidence points down · 64% evidence 34.6 out of 100 Growth Capital Valuation Relative
27. [Daqo New Energy Corp.](https://www.sectoralpha.in/us/stocks/dq) DQ · quiet · Most evidence points down · 64% evidence 33.5 out of 100 Growth Capital Valuation Relative
28. Trio-Tech International TRT · Too little evidence to rank firmly · 0% evidence 50.0 out of 100 Growth Capital Valuation Relative
29. Atomera Incorporated ATOM · quiet · Too little evidence to rank firmly · 49% evidence 38.4 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Semiconductor Equipment & Materials](https://www.sectoralpha.in/us/sectors/semiconductor-equipment-materials), all 29 compared on one page. ## Which companies are close to Camtek Ltd. in size? Camtek Ltd. is the 12th largest of 26 Semiconductor Equipment & Materials companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Nova, Amkor Technology, Inc. and FormFactor, Inc. Just below it: Kulicke and Soffa Industries, Inc., AXT, Inc. and IPG Photonics Corporation. ### Semiconductor Equipment & Materials companies close in size

1. [Nova Ltd.](https://www.sectoralpha.in/us/stocks/nvmi) $9.6 billion
2. [Amkor Technology, Inc.](https://www.sectoralpha.in/us/stocks/amkr) $9.3 billion
3. [FormFactor, Inc.](https://www.sectoralpha.in/us/stocks/form) $7.6 billion
4. Camtek Ltd. $5.2 billion
5. [Kulicke and Soffa Industries, Inc.](https://www.sectoralpha.in/us/stocks/klic) $3.8 billion
6. [AXT, Inc.](https://www.sectoralpha.in/us/stocks/axti) $3.3 billion
7. [IPG Photonics Corporation](https://www.sectoralpha.in/us/stocks/ipgp) $3.2 billion

[All 26 Semiconductor Equipment & Materials companies, largest first](https://www.sectoralpha.in/us/sectors/semiconductor-equipment-materials#all-companies)

### Companies close in size in other industries

1. [Cavco Industries, Inc.](https://www.sectoralpha.in/us/stocks/cvco) $5.1 billion · Residential Construction
2. [Merit Medical Systems, Inc.](https://www.sectoralpha.in/us/stocks/mmsi) $5.1 billion · Medical Instruments & Supplies
3. Camtek Ltd. $5.1 billion
4. [VSE Corporation](https://www.sectoralpha.in/us/stocks/vsec) $5 billion · Aerospace & Defense
5. [Sabra Health Care REIT, Inc.](https://www.sectoralpha.in/us/stocks/sbra) $5 billion · REIT - Healthcare Facilities

## What else do people ask about Camtek Ltd.? ### What were Camtek Ltd. Ltd.'s latest quarterly results? Camtek Ltd. reported revenue of $133 M and net profit of $23.3 M for the Jun 2026 quarter. Revenue rose 8.0% and profit fell 30.8% compared with a year earlier. Earnings per share were $0.46. The operating margin was 20.4%, 5.5 percentage points lower than a year earlier (as of 3 November 2026). ### What is Camtek Ltd. Ltd.'s market cap? Camtek Ltd.'s market capitalisation is $5.2 B at a stock price of $112.37. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Camtek Ltd. Ltd. performing? Camtek Ltd.'s share price has been moving sideways for 5 weeks. In its latest quarter, revenue rose 8.0% and profit fell 30.8% compared with a year earlier. Over the past 13 weeks it has done worse than the S&P 500, for 4 weeks running (as of 3 November 2026). ### Will Camtek Ltd. Ltd.'s stock price go up? This page does not forecast Camtek Ltd.'s stock price. What it shows instead: the stock price is $112.37, and it has been moving sideways for 5 weeks. Nobody can reliably say which way a price will move, and this site does not try (as of 3 November 2026). ### Where is Camtek Ltd. Ltd. in its business cycle? Camtek Ltd.'s FY25 operating margin was 26.6%, against a 5-year range of 20.7% to 26.6%: the top of its range, a record year. When profit is at a record, every ratio looks better than usual, and the story depends on margins staying high. The latest quarter was 20.4%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Camtek Ltd. Ltd. story? The main question: the share price moved −9.2% in a year while yearly earnings per share moved −56.9%. The difference came from the market paying a higher multiple. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Camtek Ltd. Ltd. a stock worth studying right now? What the numbers show: Camtek Ltd.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: whether earnings grow into a price that has already moved. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ## Lists

- US tech stocks: https://www.sectoralpha.in/us-tech-stocks

This is research, not advice. We’re not SEBI-registered.